GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Cash Flow from Discontinued Operations

Immunoclin (Immunoclin) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Immunoclin's cash flow from discontinued operations for the three months ended in Oct. 2014 was $0.00 Mil. It means Immunoclin received $0.00 Mil from the sale of part of business quarterly. Immunoclin's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Immunoclin Cash Flow from Discontinued Operations Historical Data

The historical data trend for Immunoclin's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Cash Flow from Discontinued Operations Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Cash Flow from Discontinued Operations
- - -

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immunoclin Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunoclin Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Immunoclin's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
BOM:506128 ASX:ATX OSTO:ANNX IMUN ASX:FIJ ASX:FTT ATRX TSXV:THRM WAR:BLR FNAM ASX:NC6 XCNQ:VP ENLV ASX:RAC VODG TSXV:MFS OSTO:A1M XSAT:CLINE B ASX:MEB XCNQ:LILY
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Website
http://www.immunoclin.com
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines